Revenue and profitability:
- Revenue: USD 10,845,000,000 for Q3 2025 (calendar Q3).
- Gross Profit: USD 7,358,000,000; Gross Margin: 67.85%.
- Operating Income: USD 4,263,000,000; Operating Margin: 39.31%.
- Net Income: USD 3,478,000,000; Net Margin: 32.07%.
- EBITDA: USD 5,140,000,000; EBITDA Margin: ~39.31%.
- EPS: USD 2.23; Diluted EPS: USD 2.23.
- YoY vs. QoQ growth (as provided in the data): Revenue YoY +9.42%, QoQ +6.95%; Gross Profit YoY +12.42%, QoQ +7.24%; Operating Income YoY +16.67%, QoQ +13.59%; Net Income YoY +12.85%, QoQ +14.75%.
Liquidity and leverage:
- Current Ratio: 2.76; Quick Ratio: 2.00; Cash Ratio: 0.491.
- Debt Ratio: 0.747; Total Debt to Capitalization: 1.279; Long-Term Debt to Capitalization: 1.353.
- Interest Coverage: 18.53x.
- Cash per Share: USD 2.59; Book value per share not provided; Price-to-Book ratio in the data shows a negative value (PBV −23.14), suggesting substantial accounting considerations in the reported book value.
Efficiency and turnover:
- Receivables Turnover: 1.747x; Payables Turnover: 2.55x; Inventory Turnover: 0.562x; Asset Turnover: 0.162x; Days Sales Outstanding: 51.53 days; Days Inventory Outstanding: 160.26 days; CCC: 176.44 days.
Valuation and market metrics:
- Price-to-Earnings (P/E): 18.15x; Price-to-Sales (P/S): 23.29x; Price-to-Book (P/B): negative (−23.14x) indicating abnormal balance sheet metrics or accounting treatment.
- Dividends: Dividend Yield: 0.0% (no payout ratio provided in the data).
- Enterprise Value Multiple: 58.09x; Price/Earnings to Growth (PEG): 1.264x.